Logos Global Management LP Portfolio Holdings

Logos Global Management LP

  • $1.07 Billion
  • Q1 2024

Logos Global Management LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.07 Billion distributed in 57 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ideaya Biosciences, Inc. with a value of $65.8M, Immunocore Holdings PLC with a value of $58.5M, Immunovant, Inc. with a value of $57.4M, Ocular Therapeutix, Inc with a value of $52.9M, and Sarepta Therapeutics, Inc. with a value of $51.8M.

Examining the 13F form we can see an increase of $134M in the current position value, from $939M to 1.07B.

Logos Global Management LP is based out at San Francisco, CA

Below you can find more details about Logos Global Management LP portfolio as well as his latest detailed transactions.

Portfolio value $1.07 Billion
Healthcare: $1.07 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.76B
$65.8 Million 6.13% of portfolio
1,500,000
Q1 2024 Reduced 16.67%
$2.15B
$58.5 Million 5.45% of portfolio
900,000
Q1 2024 Added 125.0%
$3.28B
$57.4 Million 5.34% of portfolio
1,775,000
Q1 2024 Added 47.92%
$439M
$52.9 Million 4.93% of portfolio
5,811,436
Q1 2024 Added 45.29%
$11.4B
$51.8 Million 4.83% of portfolio
400,000
Q1 2024 New
$391M
$49.6 Million 4.62% of portfolio
4,383,875
Q4 2023 Added 17.09%
$1.65B
$49.1 Million 4.58% of portfolio
1,730,000
Q1 2024 Reduced 7.98%
$4.31B
$47 Million 4.38% of portfolio
800,000
Q1 2024 Reduced 15.79%
$1.61B
$35 Million 3.26% of portfolio
1,300,000
Q1 2024 Added 1.96%
$753M
$31.9 Million 2.97% of portfolio
1,476,061
Q1 2024 Added 269.02%
$1.34B
$29.7 Million 2.77% of portfolio
9,000,000
Q1 2024 New
$1.56B
$27.3 Million 2.54% of portfolio
650,000
Q1 2024 New
$1.03B
$24.8 Million 2.31% of portfolio
575,000
Q1 2024 New
$230M
$21.9 Million 2.04% of portfolio
3,050,000
Q1 2024 Reduced 38.38%
$226M
$20.3 Million 1.89% of portfolio
5,032,501
Q3 2023 Added 79.89%
$874M
$20.2 Million 1.88% of portfolio
800,000
Q4 2023 Added 33.33%
$58.1M
$16.4 Million 1.53% of portfolio
40,000,000
Q1 2024 New
$1.42B
$14.4 Million 1.34% of portfolio
650,000
Q1 2024 New
$477M
$12.3 Million 1.14% of portfolio
700,000
Q1 2024 Added 16.67%
$1.07B
$11.9 Million 1.11% of portfolio
700,000
Q1 2024 New
$841M
$10.5 Million 0.98% of portfolio
1,000,000
Q1 2024 New
$170M
$9.25 Million 0.86% of portfolio
6,250,000
Q1 2024 New
$206M
$9.18 Million 0.86% of portfolio
1,350,000
Q1 2024 Reduced 18.67%
$1.09B
$8.33 Million 0.78% of portfolio
350,000
Q1 2024 New
$150M
$7.59 Million 0.71% of portfolio
2,200,000
Q1 2024 New
$4.57B
$7.01 Million 0.65% of portfolio
100,000
Q1 2024 Reduced 93.85%
$1.38B
$6.4 Million 0.6% of portfolio
300,000
Q1 2024 New
$49.5M
$6.05 Million 0.56% of portfolio
3,100,000
Q1 2024 Reduced 47.01%
$2.23B
$5.65 Million 0.53% of portfolio
150,000
Q1 2024 New
$93.7M
$5.13 Million 0.48% of portfolio
1,000,000
Q1 2024 New
$13.2M
$4.79 Million 0.45% of portfolio
3,469,927
Q1 2024 New
$42.7M
$4.29 Million 0.4% of portfolio
1,925,000
Q1 2024 New
$106M
$3.65 Million 0.34% of portfolio
2,900,000
Q4 2023 Reduced 37.63%
$363M
$2.2 Million 0.21% of portfolio
257,980
Q1 2024 Reduced 48.4%
$34M
$854,000 0.08% of portfolio
493,827
Q3 2023 New
$37.9M
$555,000 0.05% of portfolio
421,184
Q1 2023 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 65.11%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 32.71%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 66.67%
Boundless Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Leap Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 412.65%
Neumora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q4 2023 New
-
$0 0.0% of portfolio
-
Q1 2021 New
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 57
  • Current Value $1.07 Billion
  • Prior Value $939 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 23 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email